Q3 2021 Holdings
Filed 2021-11-16 | 108 holdings | $45.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $21.8M | 455,300 | 47.8% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $12.1M | 194,000 | 26.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $4.0M | 180,000 | 8.8% |
| Affirm Hldgs Inc(AFRM) | COM CL A | 00827B106 | $2.9M | 24,500 | 6.4% |
| Anavex Life Sciences Corp(AVXL) | COM NEW | 032797300 | $1.3M | 70,500 | 2.8% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $683.0K | 102,500 | 1.5% |
| Coinbase Global Inc(COIN) | COM CL A | 19260Q107 | $682.0K | 3,000 | 1.5% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $597.0K | 58,500 | 1.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $465.0K | 90,000 | 1.0% |
| Actinium Pharmaceuticals Inc(ATNM) | COM | 00507W206 | $332.0K | 37,500 | 0.7% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $284.0K | 35,000 | 0.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $111.0K | 1,500 | 0.2% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $104.0K | 6,500 | 0.2% |
| Cleveland-Cliffs Inc New(CLF) | COM | 185899101 | $63.0K | 3,200 | 0.1% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $34.5K | 268,200 | 0.1% |
| Clearside Biomedical Inc(CLSDUSD) | CLSD | 185063104 | $14.8K | 2,467,500 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $8.2K | 466,000 | 0.0% |
| Fubotv Inc(FUBO) | COM | 35953D104 | $6.1K | 253,700 | 0.0% |
| Upstart Hldgs Inc(UPST) | COM | 91680M107 | $5.4K | 17,100 | 0.0% |
| Inmune BIO Inc(INMB) | COM | 45782T105 | $5.3K | 275,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $4.4K | 173,500 | 0.0% |
| Aspira Womens Health Inc | COM | 04537Y109 | $3.7K | 1,130,720 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.9K | 161,500 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $2.9K | 25,900 | 0.0% |
| Hancock Jaffe Laboratories I | COM NEW | 41015N304 | $2.7K | 262,500 | 0.0% |
| Icad Inc(ICADUSD) | COM NEW | 44934S206 | $2.4K | 224,500 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $2.1K | 116,900 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $2.1K | 40,000 | 0.0% |
| Nuance Communications Inc | COM | 67020Y100 | $2.1K | 37,500 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.0K | 60,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.9K | 10,500 | 0.0% |
| Inhibikase Therapeutics Inc | COM | 45719W106 | $1.9K | 1,010,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $1.9K | 85,000 | 0.0% |
| Affimed N V | COM | N01045108 | $1.7K | 281,300 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $1.7K | 239,000 | 0.0% |
| Amazon.com Inc(AMZN) | COM | 023135106 | $1.6K | 500 | 0.0% |
| Goodrx Hldgs Inc(GDRX) | COM CL A | 38246G108 | $1.6K | 40,000 | 0.0% |
| Chevron Corp New(CVX) | COM | 166764100 | $1.6K | 16,000 | 0.0% |
| Matterport Inc(MTTR*) | COM CL A | 577096100 | $1.6K | 82,500 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $1.5K | 50,000 | 0.0% |
| Oncternal Therapeutics Inc | COM | 68236P107 | $1.5K | 360,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $1.3K | 170,500 | 0.0% |
| Oncocyte Corporation | COM | 68235C107 | $1.2K | 330,000 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.1K | 158,500 | 0.0% |
| Helius MED Technologies Inc | COM CL A NEW | 42328V603 | $1.0K | 70,616 | 0.0% |
| Medicenna Therapeutics Corp(MDNAF) | COM | 58490H107 | $970 | 350,000 | 0.0% |
| Katapult Holdings Inc | COM | 485859102 | $950 | 175,000 | 0.0% |
| PDS Biotechnology Corp(PDSB) | COM | 70465T107 | $894 | 60,000 | 0.0% |
| Cimarex Energy Co(XECEUR) | COM | 171798101 | $872 | 10,000 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $826 | 63,500 | 0.0% |